See the DrugPatentWatch profile for Temodar
What is Temodar used for?
Temodar is the brand name for temozolomide, a chemotherapy medicine. It’s used to treat certain brain tumors, including glioblastoma and some types of astrocytoma, usually when the cancer is newly diagnosed, returning after treatment, or progressing.
How does Temodar work?
Temodar is an oral chemotherapy drug. After it enters the body, it converts into a compound that damages tumor cell DNA, which helps stop or slow tumor growth.
How is Temodar usually taken?
Temodar is taken by mouth in treatment cycles. The exact schedule and dose depend on the cancer type (and whether it’s newly diagnosed vs. recurrent) and the treatment plan your oncology team prescribes.
What side effects do patients commonly ask about?
Common side effects can include low blood counts (which can raise infection risk), nausea and vomiting, tiredness, constipation or diarrhea, and appetite changes. Your oncology team typically monitors blood counts closely during treatment.
Who should not take Temodar or who needs extra caution?
People with significant blood count problems may need dose adjustments or more frequent monitoring. Extra caution is also needed with other medicines that affect bone marrow or with conditions that increase infection risk.
What monitoring happens during treatment?
Because Temodar can lower blood counts, clinicians typically monitor complete blood counts during therapy and adjust dosing if counts drop too low.
Is Temodar the only option?
Temodar is one temozolomide brand. There may be other brands or formulations of temozolomide available, but the exact choices depend on your country and insurance coverage.
If you tell me your situation, I can tailor the answer
If you share the cancer type (for example, glioblastoma), whether it’s newly diagnosed or recurrent, and what your doctor said about the dosing schedule, I can explain what to expect more specifically (timing of cycles, typical monitoring, and common questions to ask).
Sources: None provided.